Dabigatran etexilate

Dabigatran etexilate Reactions 1680, p108 - 2 Dec 2017 Haemopericardium and cardiac tamponade: case report An 87-year-old man developed spontaneous haemopericardium and cardiac tamponade during treatment with dabigatran etexilate [route not stated]. The man was hospitalised with worsening dyspnoea on exertion. Two months ago, he was prescribed with dabigatran etexilate 150mg twice daily for atrial fibrillation (AF), along with metoprolol. A transthoracic echocardiogram (TTE) was normal. Consequently, he experienced progressive oedema, renal insufficiency, hypotension and tachycardia. His other medications included furosemide, metolazone and metoprolol. His RR was 18 breaths/min, O saturation was 95% on room air, BP was 90/50mm Hg, HR was 112 beats/min and body mass index was 25.83 kg/m . He experienced bilateral, pitting lower extremity oedema and jugular venous distention with a positive Kussmaul sign. Laboratory test revealed acute kidney injury with increased level of creatinine from 1.0 to 1.9 mg/dL and new anaemia with haemoglobin of 9.7 g/dL. His estimated creatinine clearance was 33 mL/min. An ECG showed the AF with a ventricular rate of 110 beats/min and new low voltage in all leads. The TTE revealed a diastolic compression of the right ventricle and respiratory variation at the tricuspid inflow with >25% increase during inspiration, a severely dilated inferior vena cava without inspiratory collapse, and a large pericardial effusion with tamponade physiology. The man was treated with idarucizumab, after which emergency pericardiocentesis yielded 750cc of haemorrhagic pericardial fluid. His symptoms immediately resolved. No re- accumulation of fluid was revealed in the subsequent TTE’s. He was discharged from the hospital in stable condition, with no requirement for anticoagulation. Author comment: "Our report highlights a rare case of dabigatran-induced hemopericardium and tamponade in a patient who had no clinical evidence of pericarditis, trauma, or renal failure." Jelani Q-U-A, et al. Dabigatran-induced spontaneous hemopericardium and cardiac tamponade. Texas Heart Institute Journal 44: 370-372, No. 5, Oct 2017. Available from: URL: http://doi.org/10.14503/THIJ-16-6073 - USA 803284718 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Dabigatran etexilate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial